Home › Free Stock Grades › INSM
Insmed Incorporated (INSM) Stock Grade
INSM · Healthcare
C
Market Cap
$25.5B
P/E Ratio
—
Revenue Growth (YoY)
+66.7%
Net Margin
-210.5%
Return on Equity
—
Dividend Yield
None
About Insmed Incorporated's fundamentals
Insmed is a biotechnology company with a market capitalization of $25.5 billion that achieved strong revenue growth of 66.7% year-over-year, indicating expanding commercial traction. However, the company is currently unprofitable, reporting a net margin of -210.5% and a net loss in its latest annual statement, meaning it is spending significantly more than it generates in revenue. The company does not pay a dividend, which is typical for growth-stage biotech firms reinvesting resources into development and operations.